Benzinga | Mar 1, 2021 04:01PM EST

Adverum Biotechnologies Q4 EPS $(0.39) Misses $(0.32) Estimate

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.32) by 21.88 percent. This is a 34.48 percent decrease over losses of $(0.29) per share from the same period last year.